Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance	Insulin Resistance, Nutritional and Metabolic Diseases, acquired partial lipodystrophy, glucose metabolism disease, hyperinsulinism, metabolic disease, partial lipodystrophy	Recruiting	Phase 2	2026-08-18		NCT05470504

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Institutes of Health Clinical Center	Bethesda	United States	800

Clinical trials